1. Home
  2. HY vs ABUS Comparison

HY vs ABUS Comparison

Compare HY & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HY
  • ABUS
  • Stock Information
  • Founded
  • HY 1991
  • ABUS 2005
  • Country
  • HY United States
  • ABUS United States
  • Employees
  • HY N/A
  • ABUS N/A
  • Industry
  • HY Construction/Ag Equipment/Trucks
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HY Industrials
  • ABUS Health Care
  • Exchange
  • HY Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • HY 640.4M
  • ABUS 711.2M
  • IPO Year
  • HY N/A
  • ABUS N/A
  • Fundamental
  • Price
  • HY $36.30
  • ABUS $4.51
  • Analyst Decision
  • HY Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • HY 1
  • ABUS 2
  • Target Price
  • HY $70.00
  • ABUS $5.00
  • AVG Volume (30 Days)
  • HY 67.0K
  • ABUS 975.5K
  • Earning Date
  • HY 11-04-2025
  • ABUS 11-05-2025
  • Dividend Yield
  • HY 3.96%
  • ABUS N/A
  • EPS Growth
  • HY N/A
  • ABUS N/A
  • EPS
  • HY 1.26
  • ABUS N/A
  • Revenue
  • HY $3,950,600,000.00
  • ABUS $15,416,000.00
  • Revenue This Year
  • HY N/A
  • ABUS $138.02
  • Revenue Next Year
  • HY $0.23
  • ABUS N/A
  • P/E Ratio
  • HY $28.82
  • ABUS N/A
  • Revenue Growth
  • HY N/A
  • ABUS 53.23
  • 52 Week Low
  • HY $34.12
  • ABUS $2.71
  • 52 Week High
  • HY $68.52
  • ABUS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • HY 48.32
  • ABUS 58.09
  • Support Level
  • HY $34.15
  • ABUS $4.10
  • Resistance Level
  • HY $37.62
  • ABUS $4.54
  • Average True Range (ATR)
  • HY 1.21
  • ABUS 0.20
  • MACD
  • HY 0.09
  • ABUS -0.02
  • Stochastic Oscillator
  • HY 60.89
  • ABUS 73.23

About HY Hyster-Yale Materials Handling Inc.

Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: